Skip to main content

News

July 23, 2025

bioMérieux and Moderna Collaborate to Advance individualized Cancer Therapies

bioMérieux has a long history of collaboration with Moderna, a biotechnology company that gained worldwide recognition during the COVID-19 pandemic for its rapid development of a mRNA-based vaccine. Today, this partnership is helping accelerate the development of individualized cancer treatments.
  • June 30, 2022

    Eco-design: lighter and more responsible packaging

    We have developed more environmentally friendly brown packaging for our VIDAS® pilot range. They are now extended to other ranges.
  • June 15, 2022

    CSR: official recognitions from independent third parties

    These acknowledgements illustrate the successful integration of our CSR ambitions, with the objective to support the UN Sustainable Development Goals. ​​​​​​​